Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dodson

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Science Advances|May 6, 2026
Tunable TriPcides suppress virulence factor secretion during <i>Staphylococcus aureus</i> infection and kill dormant cellsHasan Tükenmez, Taylor M Nye, Pardeep Singh, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Development of potent and selective small-molecule human Urotensin-II antagonistsJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
ACR Open Rheumatology|November 29, 2019
Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary HypertensionAtsuko Seki, Zafia Anklesaria, Rajeev Saggar, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolaseReema K Thalji, Jeff J McAtee, Svetlana Belyanskaya, et al.
Nature Microbiology|May 3, 2022
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in womenColin J Worby, Henry L Schreiber, Timothy J Straub, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profilesJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
<i>De Novo</i> Design of Miniprotein Inhibitors of Bacterial AdhesinsAdam M Chazin-Gray, Tuscan R Thompson, Edward D B Lopatto, et al.
Circulation. Cardiovascular Quality and Outcomes|January 5, 2024
Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network RegistrySarah Donnelly, Christopher F Barnett, Erin A Bohula, et al.
Circulation. Heart Failure|May 7, 2026
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)David E Hamilton, Jackson L Shriver, Siddharth M Patel, et al.
European Heart Journal. Acute Cardiovascular Care|August 28, 2023
Prognostic significance of haemodynamic parameters in patients with cardiogenic shockDavid D Berg, Gurleen Kaur, Erin A Bohula, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Science Advances|May 6, 2026
Tunable TriPcides suppress virulence factor secretion during <i>Staphylococcus aureus</i> infection and kill dormant cellsHasan Tükenmez, Taylor M Nye, Pardeep Singh, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Development of potent and selective small-molecule human Urotensin-II antagonistsJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
ACR Open Rheumatology|November 29, 2019
Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary HypertensionAtsuko Seki, Zafia Anklesaria, Rajeev Saggar, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolaseReema K Thalji, Jeff J McAtee, Svetlana Belyanskaya, et al.
Nature Microbiology|May 3, 2022
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in womenColin J Worby, Henry L Schreiber, Timothy J Straub, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profilesJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
<i>De Novo</i> Design of Miniprotein Inhibitors of Bacterial AdhesinsAdam M Chazin-Gray, Tuscan R Thompson, Edward D B Lopatto, et al.
Circulation. Cardiovascular Quality and Outcomes|January 5, 2024
Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network RegistrySarah Donnelly, Christopher F Barnett, Erin A Bohula, et al.
Circulation. Heart Failure|May 7, 2026
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)David E Hamilton, Jackson L Shriver, Siddharth M Patel, et al.
European Heart Journal. Acute Cardiovascular Care|August 28, 2023
Prognostic significance of haemodynamic parameters in patients with cardiogenic shockDavid D Berg, Gurleen Kaur, Erin A Bohula, et al.
Pageof 12